[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pigmentary-dispersion-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pigmentary-dispersion-syndrome":23},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":5},"100614576","iop-reduction-in-pigmentary-glaucoma-using-dslt-100614576",false,"NCT07281391","IOP Reduction in Pigmentary Glaucoma Using DSLT","Direct Selective Laser Trabeculoplasty Providing Effective Intraocular Pressure Reduction in Pigmentary Glaucoma Patients","Inclusion Criteria:\n\n* Adult patients with pigmentary dispersion syndrome with elevated IOP or mild to moderate (based on AAO Preferred Practice Program criteria) pigmentary glaucoma with glaucomatous optic neuropathy and corresponding visual field\u002FRNFL loss.\n* Treatment naive, or washed out IOP ranging from ≥18-34 mmHg\n* Central corneal thickness (CCT) 480-600 µm\n* Able to complete medication washout and follow-up\n\nExclusion Criteria:\n\n* Prior incisional glaucoma surgery or glaucoma-related procedures in the study eye\n* Prior laser trabeculoplasty \\\u003C3 years\n* Prior intraocular surgery and refractive surgery, except for cataract surgery unless greater than 2 years\n* Patients anticipating cataract surgery within the follow-up period\n* History of ocular inflammation and infection\n* All other secondary glaucoma including exfoliative\n* Patients unable to have DSLT treatment","ALL",{"count":18,"type":19},45,"ESTIMATED","OBSERVATIONAL","This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.",[23,24],"Pigmentary Dispersion Syndrome","Pigmentary Dispersion Glaucoma","RECRUITING","2026-04-08",{"date":28,"type":29},"2026-04-09","ACTUAL",{"date":31,"type":29},"2026-03-19",{"date":33,"type":19},"2027-04-01",{"name":35,"class":36},"Mann Eye Institute","OTHER"]